These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27951719)

  • 1. [Molecular Genetic Testing for Acute Myeloid Leukemia].
    Janečková V; Semerád L; Ježíšková I; Dvořáková D; Čulen M; Šustková Z; Mayer J; Ráčil Z
    Klin Onkol; 2016; 29(6):411-418. PubMed ID: 27951719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.
    Falini B; Martelli MP
    Best Pract Res Clin Haematol; 2015; 28(2-3):90-7. PubMed ID: 26590764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia.
    Ziai JM; Siddon AJ;
    Am J Clin Pathol; 2015 Oct; 144(4):539-54. PubMed ID: 26386075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
    Ghanem H; Tank N; Tabbara IA
    Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markers.
    Walker AR; Marcucci G
    J Natl Compr Canc Netw; 2014 Apr; 12(4):527-34. PubMed ID: 24717571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gene mutations in acute myeloid leukemia].
    Yamaguchi H
    Rinsho Ketsueki; 2016; 57(12):2535-2542. PubMed ID: 28090023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute myeloid leukemia].
    Döhner K; Paschka P; Döhner H
    Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    Jongen-Lavrencic M; Grob T; Hanekamp D; Kavelaars FG; Al Hinai A; Zeilemaker A; Erpelinck-Verschueren CAJ; Gradowska PL; Meijer R; Cloos J; Biemond BJ; Graux C; van Marwijk Kooy M; Manz MG; Pabst T; Passweg JR; Havelange V; Ossenkoppele GJ; Sanders MA; Schuurhuis GJ; Löwenberg B; Valk PJM
    N Engl J Med; 2018 Mar; 378(13):1189-1199. PubMed ID: 29601269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics.
    Gaidzik V; Döhner K
    Semin Oncol; 2008 Aug; 35(4):346-55. PubMed ID: 18692685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
    Baldus CD; Bullinger L
    Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances of study on prognostic factors of molecular biology in acute myeloid leukemia with normal cytogenetics].
    Han TJ; Xu XP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1063-8. PubMed ID: 20723330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Acute Myeloid Leukemia Genomics, Where Do We Stand in 2018?
    Madanat YF; Kalaycio ME; Nazha A
    Acta Med Acad; 2019 Apr; 48(1):35-44. PubMed ID: 31264431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification.
    de Noronha TR; Mitne-Neto M; Chauffaille ML
    J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
    Martelli MP; Sportoletti P; Tiacci E; Martelli MF; Falini B
    Blood Rev; 2013 Jan; 27(1):13-22. PubMed ID: 23261068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical potential of introducing next-generation sequencing in patients at relapse of acute myeloid leukemia.
    Flach J; Shumilov E; Wiedemann G; Porret N; Shakhanova I; Bürki S; Legros M; Joncourt R; Pabst T; Bacher U
    Hematol Oncol; 2020 Oct; 38(4):425-431. PubMed ID: 32306411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Molecular Markers in AML Patients: A Hospital-Based Study in Lebanon.
    El Halabi L; Djaffar-Jureidini I; Hakime N; Saidy G; Chamseddine N
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S80-4. PubMed ID: 26297285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications.
    Rosli AA; Azlan A; Rajasegaran Y; Mot YY; Heidenreich O; Yusoff NM; Moses EJ
    Clin Exp Med; 2023 Aug; 23(4):1137-1159. PubMed ID: 36229751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukaemia: How to combine multiple tools.
    Merino A; Boldú L; Ermens A
    Int J Lab Hematol; 2018 May; 40 Suppl 1():109-119. PubMed ID: 29741260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.